Transcriptic

📍 Menlo Park, United States🗓 Founded 2012👥 12 employees💰 Last funded 2018
Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world. Top ten pharmaceutical companies, as well as emerging biotech companies, are using the platform to gain more reproducibility and flexibility in the design and control of their experiments. By leveraging cloud-based technologies, users can access the power of a fully automated laboratory – whether in their own labs through an on-premise deployment of TCLE or through Transcriptic’s Bioassays services – all through a simple web-based interface. Transcriptic is transforming drug discovery and synthetic biology research by helping scientists focus on accelerating discoveries instead of labor-intensive bench work.
6
Total investors
2
Early stage
3
Mid stage
1
Late stage
2012
Founded
Investor geography2 countries
United States
4
Germany
1
Investor activity2012–2018 · investors recorded per year
20121201412016320181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Transcriptic?
Transcriptic has 6 investors on record on gritt.io, including 2 early-stage backers, 3 mid-stage and 1 late-stage investors.
When did Transcriptic last raise funding?
The most recent investment in Transcriptic recorded on gritt.io was in 2018.
When was Transcriptic founded?
Transcriptic was founded in 2012.
What industry is Transcriptic in?
Transcriptic operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Transcriptic based?
Transcriptic is headquartered in Menlo Park, United States.